As Regenerative Medicine Grows in Japan, Challenges Remain
On November 11, 2021, a global conference on “The Clinical Development and Integration Strategies of Key Manufacturing Process of Regenerative Medicine in Japan” was held. Hosted by the Foundation of Medical Professionals Alliance in Taiwan, the event invited Japanese scholars to share and discuss trends and changes in Japan’s regenerative medicine industry and technology.
Hideyuki Okano, a professor in the Department of Medicine at Keio University and the chairman of the Japan Society for Regenerative Medicine (JSRM), introduced his lab’s work in regenerative medicine and iPS cell therapy.
Hideyuki Okano, a professor in the Department of Medicine at Keio University and the chairman of the Japan Society for Regenerative Medicine (JSRM), introduced his lab’s work in regenerative medicine and iPS cell therapy.
It's free! Log in now to read
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03